Table of Contents
<< Previous Issue | Dec 2003 (Vol: 2003, Issue: 42) | Next Issue >> |
- Section: Company Profile
-
Organon NV
- Section: Licensing
-
Roche Signs Deals with Ipsen and Aspreva
-
Orphan Medical Licenses Cataplexy Treatment to Celltech
- Section: Mergers & Acquisitions
-
Teva Breaks into Injectable Generics with its US$3.4 B Acquisition of SICOR
- Section: Research & Development
-
Pfizer Collaborates with Akzo Nobel over New Antipsychotic
-
Corgentech Clinches Bristol-Myers Squibb Alliance
-
AstraZeneca Extends Early-Stage Oncology Pipeline